Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New Wnt/catenin beta signaling inhibitor shows potential as cancer therapy

March 26, 2012

Scottish university receives grant to investigate spread of leukemia in the blood

March 23, 2012

FDA committee issues recommendation for Marqibo

March 23, 2012

Immunovative Therapies patents novel Th1/killer cells

March 23, 2012

CSL prepares novel humanized IL-3R-alpha-directed antibodies

March 23, 2012

First-in-human trial of H1N1 influenza vaccine using iBioLaunch technology completed

March 23, 2012

Novel naphthoquinones designed in China

March 23, 2012

Line extension for Taxol approved in Japan

March 22, 2012

Chroma Therapeutics designs new histone deacetylase inhibitors

March 22, 2012

Merck & Co. presents new potential cancer therapies

March 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...